足踝医疗设备市场－全球产业规模、份额、趋势、机会及预测（依产品类型、手术、应用、最终用户、地区及竞争格局划分），2021-2031年

全球足踝医疗设备市场预计将从2025年的54.9亿美元成长到2031年的77.4亿美元，复合年增长率（CAGR）为5.89%。该市场涵盖整形外科植入、义肢和外矫正器具系统，旨在治疗肌肉骨骼疾病、创伤和下肢畸形。这一增长主要受全球人口老化（骨关节炎发病率上升）以及需要手术修復的运动相关损伤增加所驱动。此外，糖尿病併发症盛行率的上升也显着增加了对专用重组和减压装置的需求。根据国际糖尿病联盟（IDF）2024年的数据，全球约有5.89亿成年人患有糖尿病，凸显了有效糖尿病足管理方案的重要性。

然而，植入手术的高昂费用以及产品核可所需的严格监管流程阻碍了市场扩张。这些经济和行政障碍会限制患者获得创新治疗方法的机会，并减缓医疗技术的商业化进程，尤其是在对成本高度敏感的发展中地区。因此，儘管临床对先进医疗设备的需求依然旺盛，但这些障碍限制了新解决方案在全球医疗系统中的引进和应用速度。

市场驱动因素

糖尿病足併发症发生率的不断上升是推动全球足踝医疗设备市场扩张的主要因素。高血糖症常导致周边神经病变和血管疾病，显着增加足部溃疡、夏科氏足以及最终下肢截肢的风险。这些严重的併发症需要使用专门的内固定装置、重组植入和外部矫正器具系统来维持患者的活动能力并防止截肢。美国国立卫生研究院于2025年4月发表的一项题为《下肢大截肢的机构差异》的研究显示，在确诊糖尿病足溃疡后仅一年内，就有3.8%的患者接受了下肢大截肢手术。这凸显了临床上迫切需要先进的治疗设备来有效应对这种复杂的疾病。

市场成长得益于快速的产品创新和策略核准，製造商正致力于开发用于软组织修復和踝关节不稳定的先进解决方案。该行业日益关注微创手术 (MIS) 系统和符合人体解剖结构的钢板技术，以改善患者预后并缩短復原时间。例如，史密斯医疗器材公司 (Smith & Nephew) 于 2025 年 2 月发布的 2024 年年度报告指出，该公司推出了 ULTRABRACE 系统和 ULTRABRIDGE 系统等新型手术解决方案，这些方案专为踝关节不稳和跟腱重组设计。产业整合的加剧进一步强化了这项技术进步趋势。例如，捷迈生物 (Zimmer Biomet) 宣布将于 2025 年达成最终协议，收购 Paragon 28，以积极拓展其在快速成长的足踝领域的业务。

市场挑战

全球足踝医疗设备市场的财务永续性正受到手术报销率持续下降的直接威胁。随着医疗系统寻求削减开支，整形外科手术支付模式的缩减为高价值植入技术的应用带来了挑战。当医疗机构面临复杂手术报销额下降时，他们被迫优先考虑标准治疗方法，而非更新、更昂贵的器械选择。这种财务压力限制了先进踝关节解决方案的市场准入，并由于投资回报的不确定性，阻碍了製造商在创新方面进行重大投资。

据美国足病医学协会称，美国医疗保险和医疗补助服务中心已最终确定，2025年医生诊疗费的转换係数将年减约2.83%。这种系统性的医师诊疗费下降正从根本上削弱下肢专科医疗机构的财务基础。因此，预算限制导致患者难以获得有效的重组治疗，减缓了整个踝关节器械市场的收入成长，并阻碍了整体市场的扩张。

市场趋势

随着医疗系统优先考虑成本效益高的当日手术环境，踝关节手术转移到门诊手术中心 (ASC) 的转移正在从根本上改变市场结构。这种运作模式的转变推动了对无菌预包装、高效植入系统的需求，这些系统能够减少门诊手术的围手术期时间和库存负担。器械製造商正在加速调整策略，以摆脱对停滞不前的医院手术量的依赖，并抓住这些专业机构不断增长的病例量。 Paragon 28 的案例说明了这种转变所带来的财务影响。在其 2025 年 1 月发布的「未经审核收入」新闻稿中，该公司报告称，2024 财年全年收入约为 2.56 亿美元（同比增长 18%），这一显着增长主要得益于其专业产品组合在快速增长的门诊手术中心市场中的强劲需求。

同时，3D列印特异性植入的广泛应用正在革新外科手术规划，其製造的植入物具有高孔隙率和解剖结构相容性，能够促进骨整合。这项技术能够生产传统製造过程无法实现的复杂几何形状，因此在全踝置换术和需要保留骨骼的大规模重组手术中尤其有利。整合了积层製造的公司正在市场上实现显着的收入成长。例如，Enobis在2025年2月发布的「2024年第四季及全年业绩报告」中指出，其重建部门的营收成长了59%，这主要得益于其策略性地整合了从LimaCorporate收购的先进3D列印技术。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球足踝医疗设备市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类型（固定装置、人工关节、关节移植、软组织整形外科装置、矫正器具及支撑装置）
  • 透过手术（骨折修復、截骨、固定或其他）
  • 依应用领域（创伤/微骨折、韧带损伤、类风湿性关节炎/骨关节炎、糖尿病足病变、其他）
  • 依最终使用者（医院、整形外科诊所、门诊手术中心、復健中心）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美足踝医疗设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

7. 欧洲足踝医疗设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区足踝医疗设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲足踝医疗设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美足踝医疗设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球足踝医疗设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• DePuy Synthes
• Arthrex, Inc.
• Wright Medical Group NV
• Medtronic plc
• CONMED Corporation
• Colfax Corporation
• Integra LifeSciences Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Foot & Ankle Devices Market is projected to rise from a valuation of USD 5.49 Billion in 2025 to USD 7.74 Billion by 2031, achieving a CAGR of 5.89%. This market encompasses orthopedic implants, prosthetics, and external bracing systems designed to address musculoskeletal disorders, trauma, and lower extremity deformities. The growth is largely fueled by an aging global population susceptible to osteoarthritis and a rising frequency of sports-related injuries that necessitate surgical repair. Furthermore, the increasing prevalence of diabetes-related complications creates substantial demand for specialized reconstructive and offloading devices. Data from the International Diabetes Federation in 2024 indicates that approximately 589 million adults were living with diabetes worldwide, underscoring the critical necessity for effective diabetic foot management solutions.

However, the market's expansion is hindered by the high costs associated with implant procedures and the rigorous regulatory processes required for product approval. These financial and bureaucratic barriers can restrict patient access to innovative therapies and slow the commercialization of medical technologies, particularly in developing regions where cost sensitivity is high. Consequently, while the clinical need for advanced devices remains strong, these hurdles limit the speed at which new solutions can be adopted and distributed across global healthcare systems.

Market Driver

The increasing incidence of diabetes-related foot complications acts as a primary driver for the expansion of the Global Foot & Ankle Devices Market. Elevated blood sugar levels frequently result in peripheral neuropathy and vascular disease, conditions that significantly heighten the risk of foot ulcers, Charcot foot, and subsequent lower limb amputations. These severe complications demand the use of specialized internal fixation devices, reconstruction implants, and external bracing systems to preserve mobility and prevent limb loss. A study by the National Institutes of Health released in April 2025, titled 'Facility-Level Variation in Major Leg Amputation,' revealed that major leg amputation was performed on 3.8% of patients within just one year of a diabetic foot ulcer diagnosis, highlighting the urgent clinical need for advanced therapeutic devices to manage complex pathologies effectively.

Market growth is further accelerated by rapid product innovation and strategic approvals, as manufacturers create sophisticated solutions for soft tissue repair and ankle instability. There is a growing industry focus on minimally invasive surgery (MIS) systems and anatomically contoured plating technologies aimed at improving patient outcomes and shortening recovery times. For instance, Smith+Nephew's 'Annual Report 2024,' published in February 2025, noted the launch of new procedure solutions such as the ULTRABRACE and ULTRABRIDGE systems designed for ankle instability and Achilles reconstruction. This trend toward technological advancement is bolstered by significant industry consolidation, as seen in Zimmer Biomet's 2025 announcement of a definitive agreement to acquire Paragon 28 to aggressively expand its footprint in the high-growth foot and ankle segment.

Market Challenge

The financial sustainability of the Global Foot & Ankle Devices Market is directly challenged by ongoing reductions in reimbursement rates for surgical procedures. As healthcare systems aim to reduce expenditures, the declining payment models for orthopedic interventions create a difficult environment for the adoption of premium implant technologies. When providers encounter lower compensation for complex surgeries, they are often forced to prioritize standard treatments over newer, more expensive device options. This financial pressure restricts the entry of advanced foot and ankle solutions into the market and discourages manufacturers from investing heavily in innovation due to uncertain returns on investment.

According to the American Podiatric Medical Association in 2025, the Centers for Medicare and Medicaid Services finalized a conversion factor reduction of approximately 2.83 percent compared to the previous year. This systematic decrease in physician payment rates fundamentally strains the operational economics of medical practices specializing in lower extremity care. Consequently, these budgetary constraints limit patient access to effective reconstructive therapies and slow the overall revenue trajectory of the foot and ankle devices sector, hindering broader market growth.

Market Trends

The shift of foot and ankle procedures to Ambulatory Surgical Centers (ASCs) is fundamentally reshaping the market as healthcare systems prioritize cost-effective, same-day surgical environments. This operational transition drives demand for sterile-packaged, streamlined implant systems that reduce turnover time and inventory burdens in outpatient settings. Device manufacturers are increasingly adapting their strategies to capture expanding caseloads in these specialized facilities, moving away from reliance on stagnant hospital volumes. The financial impact of this migration is illustrated by Paragon 28, which reported in its January 2025 'Preliminary Unaudited Revenue' press release a full-year 2024 revenue of approximately $256 million, an 18% increase largely driven by the robust adoption of its specialized portfolio in the fast-growing ASC space.

Simultaneously, the proliferation of 3D-printed patient-specific implants is revolutionizing surgical planning by enabling the creation of highly porous, anatomically matched devices that enhance osseointegration. This technology allows for the fabrication of complex geometries that traditional manufacturing cannot achieve, offering specific benefits for total ankle replacements and large reconstructive cases where bone preservation is critical. The market is seeing a significant revenue surge for organizations that have integrated additive manufacturing; for example, Enovis reported in its 'Fourth Quarter and Full Year 2024 Results' in February 2025 that its Reconstructive segment achieved a 59% reported revenue increase, a metric significantly bolstered by the strategic integration of advanced 3D-printing technologies acquired from LimaCorporate.

Key Market Players

• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• DePuy Synthes
• Arthrex, Inc.
• Wright Medical Group N.V.
• Medtronic plc
• CONMED Corporation
• Colfax Corporation
• Integra LifeSciences Corporation

Report Scope

In this report, the Global Foot & Ankle Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Foot & Ankle Devices Market, By Product Type

• Fixation Devices
• Prosthesis
• Joint Implants
• Soft Tissue Orthopedic Devices
• Bracing & Support Devices

Foot & Ankle Devices Market, By Procedure

• Fracture Repair
• Osteotomy
• Fusion Procedures
• Others

Foot & Ankle Devices Market, By Application

• Trauma & Hair line Fractures
• Ligament Injuries
• Rheumatoid Arthritis & Osteoarthritis
• Diabetic Foot Diseases
• Others

Foot & Ankle Devices Market, By End User

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgery Centers
• Rehabilitation Centers

Foot & Ankle Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Foot & Ankle Devices Market.

Available Customizations:

Global Foot & Ankle Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Foot & Ankle Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Fixation Devices, Prosthesis, Joint Implants, Soft Tissue Orthopedic Devices, Bracing & Support Devices)
  • 5.2.2. By Procedure (Fracture Repair, Osteotomy, Fusion Procedures, Others)
  • 5.2.3. By Application (Trauma & Hair line Fractures, Ligament Injuries, Rheumatoid Arthritis & Osteoarthritis, Diabetic Foot Diseases, Others)
  • 5.2.4. By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Rehabilitation Centers)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Foot & Ankle Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Procedure
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Foot & Ankle Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Procedure
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Foot & Ankle Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Procedure
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Foot & Ankle Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Procedure
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Foot & Ankle Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Procedure
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Foot & Ankle Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Procedure
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Foot & Ankle Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Procedure
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Foot & Ankle Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Procedure
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Foot & Ankle Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Procedure
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Foot & Ankle Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Procedure
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Foot & Ankle Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Procedure
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Foot & Ankle Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Procedure
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Foot & Ankle Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Procedure
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Foot & Ankle Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Procedure
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Foot & Ankle Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Procedure
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Foot & Ankle Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Procedure
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Foot & Ankle Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Procedure
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Foot & Ankle Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Procedure
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Foot & Ankle Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Procedure
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Foot & Ankle Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Procedure
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Foot & Ankle Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Procedure
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Foot & Ankle Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Procedure
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Foot & Ankle Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Procedure
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Foot & Ankle Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Procedure
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Foot & Ankle Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Stryker Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Zimmer Biomet Holdings, Inc.
• 15.3. Smith & Nephew plc
• 15.4. DePuy Synthes
• 15.5. Arthrex, Inc.
• 15.6. Wright Medical Group N.V.
• 15.7. Medtronic plc
• 15.8. CONMED Corporation
• 15.9. Colfax Corporation
• 15.10. Integra LifeSciences Corporation

16. Strategic Recommendations

17. About Us & Disclaimer